These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11518490)

  • 61. Sudden infant death syndrome and secretin treatment for autism.
    Blatt SD; Meguid V; Church CC
    Curr Opin Pediatr; 2000 Apr; 12(2):179-83. PubMed ID: 10763770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risperidone improves behavior in children with autism.
    Caicedo C; Williams SH
    J Fam Pract; 2002 Nov; 51(11):915. PubMed ID: 12485538
    [No Abstract]   [Full Text] [Related]  

  • 63. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.
    Ghaleiha A; Ghyasvand M; Mohammadi MR; Farokhnia M; Yadegari N; Tabrizi M; Hajiaghaee R; Yekehtaz H; Akhondzadeh S
    J Psychopharmacol; 2014 Jul; 28(7):677-85. PubMed ID: 24132248
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.
    Bolman WM; Richmond JA
    J Autism Dev Disord; 1999 Jun; 29(3):191-4. PubMed ID: 10425581
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    Neuropsychopharmacology; 2003 May; 28(5):1014-5. PubMed ID: 12700706
    [No Abstract]   [Full Text] [Related]  

  • 66. Brief report: case reports on naltrexone use in children with autism: controlled observations regarding benefits and practical issues of medication management.
    Williams PG; Allard A; Sears L; Dalrymple N; Bloom AS
    J Autism Dev Disord; 2001 Feb; 31(1):103-8. PubMed ID: 11439748
    [No Abstract]   [Full Text] [Related]  

  • 67. The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.
    Willemsen-Swinkels SH; Buitelaar JK; van Engeland H
    Biol Psychiatry; 1996 Jun; 39(12):1023-31. PubMed ID: 8780837
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.
    Handen BL; Johnson CR; Lubetsky M
    J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of l-Carnosine Supplementation on Sleep Disorders and Disease Severity in Autistic Children: A Randomized, Controlled Clinical Trial.
    Mehrazad-Saber Z; Kheirouri S; Noorazar SG
    Basic Clin Pharmacol Toxicol; 2018 Jul; 123(1):72-77. PubMed ID: 29430839
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lofexidine in hyperactive and impulsive children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1396-7. PubMed ID: 12447025
    [No Abstract]   [Full Text] [Related]  

  • 72. Placebo-controlled acute dosage naltrexone study in young autistic children.
    Willemsen-Swinkels SH; Buitelaar JK; Weijnen FG; van Engeland H
    Psychiatry Res; 1995 Oct; 58(3):203-15. PubMed ID: 8570776
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Secretin for refractory schizophrenia.
    Sheitman BB; Knable MB; Jarskog LF; Chakos M; Boyce LH; Early J; Lieberman JA
    Schizophr Res; 2004 Feb; 66(2-3):177-81. PubMed ID: 15061251
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autism, an extreme challenge to integrative medicine. Part 2: medical management.
    Kidd PM
    Altern Med Rev; 2002 Dec; 7(6):472-99. PubMed ID: 12495373
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of complementary and alternative treatments for children with autistic spectrum disorders is increasing.
    Levy SE; Hyman SL
    Pediatr Ann; 2003 Oct; 32(10):685-91. PubMed ID: 14606219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brief report: a double-blind study of naltrexone in infantile autism.
    Leboyer M; Bouvard MP; Launay JM; Tabuteau F; Waller D; Dugas M; Kerdelhue B; Lensing P; Panksepp J
    J Autism Dev Disord; 1992 Jun; 22(2):309-19. PubMed ID: 1345670
    [No Abstract]   [Full Text] [Related]  

  • 77. Galantamine may be effective in treating autistic disorder.
    Niederhofer H; Staffen W; Mair A
    BMJ; 2002 Dec; 325(7377):1422. PubMed ID: 12480867
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacotherapy for autistic children: a summary of research.
    Campbell M; Cohen IL; Anderson LT
    Can J Psychiatry; 1981 Jun; 26(4):265-73. PubMed ID: 6117366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome.
    Metz DC; Buchanan M; Purich E; Fein S
    Aliment Pharmacol Ther; 2001 May; 15(5):669-76. PubMed ID: 11328261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.
    Niederhofer H; Staffen W; Mair A
    Hum Psychopharmacol; 2003 Jul; 18(5):389-93. PubMed ID: 12858327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.